Gilead-backed Hookipa Pharma files for IPO

Hookipa Pharma, a Phase 2 biotech developing T cell immunotherapies for various cancers, filed with the SEC to raise up to $86 million in an initial public offering.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news